• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Presence of sarcopenic obesity and evaluation of the associated muscle quality in Japanese older men with prostate cancer undergoing androgen deprivation therapy.

作者信息

Kimura Yosuke, Yamada Minoru, Ohji Shunsuke, Ishiyama Daisuke, Nishio Naohito, Otobe Yuhei, Koyama Shingo, Suzuki Mizue, Ichikawa Takeo, Ito Daisuke, Maehori Naomi, Nagae Hiroshi

机构信息

Graduate School of Comprehensive Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan; Department of Rehabilitation, Tokyo Shinjuku Medical Center, Japan Community Health care Organization, 5-1 Tukudocho, Shinjuku-ku, Tokyo 162-8543, Japan.

Graduate School of Comprehensive Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan.

出版信息

J Geriatr Oncol. 2019 Sep;10(5):835-838. doi: 10.1016/j.jgo.2019.03.017. Epub 2019 Apr 4.

DOI:10.1016/j.jgo.2019.03.017
PMID:30956136
Abstract
摘要

相似文献

1
Presence of sarcopenic obesity and evaluation of the associated muscle quality in Japanese older men with prostate cancer undergoing androgen deprivation therapy.接受雄激素剥夺治疗的日本老年前列腺癌男性患者中肌肉减少性肥胖的存在情况及相关肌肉质量评估
J Geriatr Oncol. 2019 Sep;10(5):835-838. doi: 10.1016/j.jgo.2019.03.017. Epub 2019 Apr 4.
2
The effects of androgen deprivation therapy on lipid metabolism and body composition in Japanese patients with prostate cancer.雄激素剥夺疗法对日本前列腺癌患者脂代谢和身体成分的影响。
Jpn J Clin Oncol. 2011 Apr;41(4):577-81. doi: 10.1093/jjco/hyr005. Epub 2011 Feb 4.
3
Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.前列腺癌患者接受36周最大雄激素阻断治疗后肌肉、脂肪和骨量的变化。
BJU Int. 2008 Jul;102(1):44-7. doi: 10.1111/j.1464-410X.2008.07539.x. Epub 2008 Mar 11.
4
Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.年龄、体重指数和血清前列腺特异性抗原与未接受雄激素剥夺治疗的前列腺癌男性的骨质流失相关。
Urology. 2004 Aug;64(2):335-40. doi: 10.1016/j.urology.2004.03.036.
5
Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition.男性起始雄激素剥夺时即刻与延迟运动：对骨密度和软组织组成的影响。
BJU Int. 2019 Feb;123(2):261-269. doi: 10.1111/bju.14505. Epub 2018 Sep 21.
6
Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?雄激素剥夺疗法（ADT）在前列腺癌男性中的应用是否会增加肌少症的风险？
Calcif Tissue Int. 2019 Oct;105(4):403-411. doi: 10.1007/s00223-019-00586-1. Epub 2019 Jul 17.
7
Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation.芬兰多中心研究：比较晚期前列腺癌间歇性雄激素剥夺疗法与持续性雄激素剥夺疗法——影响雄激素剥夺初始反应的预后标志物的中期分析
J Urol. 2008 Sep;180(3):915-9; discussion 919-20. doi: 10.1016/j.juro.2008.05.009. Epub 2008 Jul 17.
8
Long-term effects of androgen deprivation therapy in prostate cancer patients.雄激素剥夺疗法对前列腺癌患者的长期影响。
Clin Endocrinol (Oxf). 2002 Jun;56(6):779-86. doi: 10.1046/j.1365-2265.2002.01551.x.
9
Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy.根治性前列腺切除术后前列腺癌复发的男性接受雄激素剥夺治疗的结果和预后因素。
J Urol. 2018 Nov;200(5):1075-1081. doi: 10.1016/j.juro.2018.04.070. Epub 2018 Apr 27.
10
Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy.J-CAPRA 评分在碳离子放疗联合雄激素剥夺治疗高危前列腺癌患者中的应用价值。
Jpn J Clin Oncol. 2014 Apr;44(4):360-5. doi: 10.1093/jjco/hyu006. Epub 2014 Feb 28.

引用本文的文献

1
Normal Weight, Overweight and Obesity Conditions Associated to Prostate Neoplasm Stages-A Systematic Review and Meta-Analysis.与前列腺肿瘤分期相关的正常体重、超重和肥胖状况——一项系统评价与荟萃分析
Biomedicines. 2025 May 13;13(5):1182. doi: 10.3390/biomedicines13051182.
2
Influence of Androgen Deprivation Therapy on the Development of Sarcopenia in Patients with Prostate Cancer: A Systematic Review.雄激素剥夺治疗对前列腺癌患者肌少症发展的影响：系统评价。
Nutrients. 2024 Feb 26;16(5):656. doi: 10.3390/nu16050656.
3
Sarcopenic obesity in cancer.
癌症相关的肌肉减少性肥胖
Radiol Oncol. 2024 Feb 21;58(1):1-8. doi: 10.2478/raon-2024-0011. eCollection 2024 Mar 1.
4
HoSAGE: sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: study protocol for a cohort trial.HO-SAGE：雄激素剥夺治疗后中高危前列腺癌老年患者的肌肉减少症：一项队列研究方案。
BMC Cancer. 2022 Jan 18;22(1):78. doi: 10.1186/s12885-021-09105-8.
5
Skeletal Muscle-Adipose Tissue-Tumor Axis: Molecular Mechanisms Linking Exercise Training in Prostate Cancer.骨骼肌-脂肪组织-肿瘤轴：与前列腺癌运动训练相关的分子机制。
Int J Mol Sci. 2021 Apr 25;22(9):4469. doi: 10.3390/ijms22094469.
6
Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.肥胖与转移性和/或去势抵抗性前列腺癌患者的生存时间延长相关，而与肌肉减少症和肌内脂肪减少无关。
J Urol. 2021 Mar;205(3):800-805. doi: 10.1097/JU.0000000000001428. Epub 2020 Oct 20.